Expertise in
38
conditions

Dr. Mustafa Sahin

Pediatric Neurology
Department Of Neurology
300 Longwood Ave, 
Boston, MA 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Expertise in
38
conditions
Department Of Neurology
300 Longwood Ave, 
Boston, MA 

Overview

Mustafa Sahin is a Pediatric Neurologist practicing medicine in Boston, Massachusetts.

Dr. Sahin is highly rated in 38 conditions, according to our data. His clinical expertise encompasses Tuberous Sclerosis, Tuberous Sclerosis Complex, Cortical Dysplasia, and Spastic Paraplegia Type 7.

He is actively involved in clinical research, co-authoring 319 peer reviewed articles and participating in 12 clinical trials. Dr. Sahin is currently accepting new patients.

Specialties

Pediatric Neurology

Licenses

Psychiatry & Neurology in MA

Languages Spoken

English
Spanish

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Mass General Brigham Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Sentara Healthcare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE ASSISTANCE PROGRAM
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 2 Less Insurance Carriers -

Locations

Department of Neurology
300 Longwood Ave, Boston, MA 02115

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

12 Clinical Trials

Registry and Natural History Study for Early Onset Hereditary Spastic Paraplegia (HSP)
Registry and Natural History Study for Early Onset Hereditary Spastic Paraplegia (HSP)
Enrollment Status: Recruiting
Publish Date: March 18, 2026
Natural History Study of Individuals With Autism and Germline Heterozygous PTEN Mutations
Natural History Study of Individuals With Autism and Germline Heterozygous PTEN Mutations
Enrollment Status: Active_not_recruiting
Publish Date: August 06, 2026
Autism Spectrum Disorder (ASD) and Intellectual Disability (ID) Determinants in Tuberous Sclerosis Complex (TSC)
Autism Spectrum Disorder (ASD) and Intellectual Disability (ID) Determinants in Tuberous Sclerosis Complex (TSC)
Enrollment Status: Active_not_recruiting
Publish Date: August 06, 2026
Mapping the Genotype, Phenotype, and Natural History of Phelan-McDermid Syndrome
Mapping the Genotype, Phenotype, and Natural History of Phelan-McDermid Syndrome
Enrollment Status: Active_not_recruiting
Publish Date: August 06, 2026
Phase 2 Multi Center Prospective Rand. Double Blind Placebo Cont. Parallel Design Study to Evaluate Safety & Efficacy of Topical Sirolimus for Cutaneous Angiofibromas in Subjects W/ Tuberous Sclerosis Complex Followed by Opt. Open Label
Phase 2 Multi Center Prospective Rand. Double Blind Placebo Cont. Parallel Design Study to Evaluate Safety & Efficacy of Topical Sirolimus for Cutaneous Angiofibromas in Subjects W/ Tuberous Sclerosis Complex Followed by Opt. Open Label
Enrollment Status: Terminated
Publish Date: December 01, 2025
Intervention Type: Drug
Study Drug: Sirolimus
Study Phase: Phase 2
Mapping the Phenotype in Adults With Phelan-McDermid Syndrome
Mapping the Phenotype in Adults With Phelan-McDermid Syndrome
Enrollment Status: Completed
Publish Date: February 18, 2025
Intervention Type: Other
A Randomized Double-Blind Controlled Trial of Everolimus in Individuals With PTEN Mutations (RAD001XUS257T)
A Randomized Double-Blind Controlled Trial of Everolimus in Individuals With PTEN Mutations (RAD001XUS257T)
Enrollment Status: Completed
Publish Date: February 17, 2025
Intervention Type: Drug
Study Drug: Everolimus
Study Phase: Phase 1/Phase 2
Preventing Epilepsy Using Vigabatrin In Infants With Tuberous Sclerosis Complex (PREVeNT Trial) A Randomized, Double-blind, Placebo-controlled Seizure Prevention Clinical Trial for Infants With TSC
Preventing Epilepsy Using Vigabatrin In Infants With Tuberous Sclerosis Complex (PREVeNT Trial) A Randomized, Double-blind, Placebo-controlled Seizure Prevention Clinical Trial for Infants With TSC
Enrollment Status: Completed
Publish Date: August 19, 2024
Intervention Type: Drug
Study Drug: Vigabatrin
Study Phase: Phase 2
Stopping TSC Onset and Progression 2: Epilepsy Prevention in TSC Infants
Stopping TSC Onset and Progression 2: Epilepsy Prevention in TSC Infants
Enrollment Status: Completed
Publish Date: May 16, 2024
Intervention Type: Drug
Study Drug: TAVT-18 (sirolimus)
Study Phase: Phase 1/Phase 2
Rett Syndrome, MECP2 Duplication Disorder, and Rett- Related Disorders Natural History Protocol
Rett Syndrome, MECP2 Duplication Disorder, and Rett- Related Disorders Natural History Protocol
Enrollment Status: Completed
Publish Date: August 05, 2021
View 9 Less Clinical Trials

319 Total Publications

Electroencephalographic Transient Beta Event Rates in Autism and Related Neurogenetic Conditions.
Electroencephalographic Transient Beta Event Rates in Autism and Related Neurogenetic Conditions.
Journal: medRxiv : the preprint server for health sciences
Published: August 20, 2026
Similar Doctors
Expertise in
11
conditions
Dr. Tobias Loddenkemper
Pediatric Neurology
Expertise in
11
conditions
Dr. Tobias Loddenkemper
Pediatric Neurology
Referral may be required

Department Of Neurology

300 Longwood Ave, 
Boston, MA 
 (0.1 miles away)
617-919-5323
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Tobias Loddenkemper is a Pediatric Neurologist practicing medicine in Boston, Massachusetts. Dr. Loddenkemper is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Status Epilepticus, Seizures, Epilepsy in Children, and Epilepsy. Dr. Loddenkemper is currently accepting new patients.

Expertise in
21
conditions
Dr. Elizabeth A. Thiele
Pediatric Neurology | Neurology
Expertise in
21
conditions
Dr. Elizabeth A. Thiele
Pediatric Neurology | Neurology
Referral may be required

Massachusetts General Physicians Organization Inc

55 Fruit St, 
Boston, MA 
 (2.6 miles away)
617-724-0287
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Elizabeth Thiele is a Pediatric Neurologist and a Neurologist practicing medicine in Boston, Massachusetts. Dr. Thiele is highly rated in 21 conditions, according to our data. Her clinical expertise encompasses Tuberous Sclerosis Complex, Tuberous Sclerosis, Cortical Dysplasia, and Myoclonic Epilepsy. Dr. Thiele is currently accepting new patients.

Expertise in
14
conditions
Dr. Christopher A. Walsh
Pediatric Neurology
Expertise in
14
conditions
Dr. Christopher A. Walsh
Pediatric Neurology
Referral may be required

Office

3 Blackfan Cir, 
Boston, MA 
 (0.2 miles away)
617-919-2923
Languages Spoken:
English
See accepted insurances

Christopher Walsh is a Pediatric Neurologist practicing medicine in Boston, Massachusetts. Dr. Walsh is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Polymicrogyria, Cortical Dysplasia, Microcephaly, and Achalasia Microcephaly Syndrome.

Frequently Asked Questions about Dr. Mustafa Sahin

How do I make an appointment with Dr. Mustafa Sahin?

You can book an appointment with Dr. Mustafa Sahin by calling their office at 617-919-5323. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Mustafa Sahin a top-rated expert for Tuberous Sclerosis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mustafa Sahin is classified as an Elite expert for Tuberous Sclerosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Mustafa Sahin specialize in?

While Dr. Mustafa Sahin is a Pediatric Neurology, they have specific expertise in Tuberous Sclerosis, Tuberous Sclerosis Complex, and Cortical Dysplasia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatric Neurology.

Does Dr. Mustafa Sahin participate in research or clinical trials?

Yes. Dr. Mustafa Sahin has published 319 articles and abstracts on conditions like Tuberous Sclerosis. You can view a list of Dr. Mustafa Sahin's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Mustafa Sahin accept my insurance?

Dr. Mustafa Sahin accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 617-919-5323 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Sahin's expertise for a condition
ConditionClose
View All 7 Distinguished Conditions
View All 25 Advanced Conditions
View All 20 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile